Dolphin Medical Services Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.
Growth
Compounded Sales Growth
10 Years:
-3%
5 Years:
63%
3 Years:
13%
TTM:
16%
Compounded Profit Growth
10 Years:
7%
5 Years:
11%
3 Years:
19%
TTM:
-43%
Stock Price CAGR
10 Years:
9%
5 Years:
40%
3 Years:
-3%
1 Year:
2%
Return on Equity
10 Years:
-2%
5 Years:
-2%
3 Years:
-1%
Last Year:
-1%
Last Updated: Unknown
No data available for the Balance Sheet data table.
Reserves and Borrowings Chart
Cash Flow
Month
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Cash from Operating Activity +
0.15
0.18
0.05
-0.12
-0.07
0.00
0.02
-0.13
0.27
-0.10
-0.07
-0.05
Cash from Investing Activity +
-0.11
-0.17
0.00
0.01
0.03
0.00
1.97
-0.01
0.00
0.00
0.00
0.00
Cash from Financing Activity +
-0.04
-0.01
-0.05
0.11
0.05
0.00
-1.99
0.15
-0.25
0.07
0.07
0.05
Net Cash Flow
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.01
0.03
-0.02
0.00
0.00
Free Cash Flow Chart
Financial Efficiency Indicators
Month
Mar 2013
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Debtor Days
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventory Days
45.62
36.50
36.50
21.47
0.00
0.00
0.00
0.00
0.00
0.00
0.00
33.18
Days Payable
0.00
12.17
73.00
0.00
0.00
Cash Conversion Cycle
45.62
24.33
-36.50
21.47
0.00
0.00
0.00
0.00
0.00
0.00
0.00
33.18
Working Capital Days
589.12
589.32
1,449.86
1,171.84
2,106.57
4,891.00
11,619.17
3,629.72
986.28
898.46
771.89
687.06
ROCE %
-5.35%
-3.69%
-2.55%
-0.05%
-0.96%
-1.56%
-1.69%
-2.02%
-1.98%
-1.45%
-0.91%
-0.83%
Financial Efficiency Indicators Chart
Share Holding Pattern
Month
Sep 2021
Dec 2021
Mar 2022
Jun 2022
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Promoters
26.44%
26.44%
26.44%
26.44%
26.44%
26.44%
26.44%
26.44%
26.44%
26.44%
26.44%
26.44%
Public
73.56%
73.56%
73.56%
73.56%
73.57%
73.56%
73.56%
73.56%
73.56%
73.56%
73.57%
73.56%
No. of Shareholders
8,181
8,838
9,073
9,117
9,099
9,138
9,145
9,150
9,136
9,360
9,349
9,358
Shareholding Pattern Chart
No. of Shareholders
This stock is not held by any mutual fund
ROCE Trend
EPS Trend
Key Financial Ratios
Month
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
FaceValue
10.00
10.00
10.00
10.00
10.00
Basic EPS (Rs.)
-0.03
-0.38
-0.57
-1.31
-0.99
Diluted EPS (Rs.)
-0.03
-0.38
-0.57
-1.31
-0.99
Cash EPS (Rs.)
0.19
-0.03
-0.09
-0.88
-0.55
Book Value[Excl.RevalReserv]/Share (Rs.)
8.50
8.53
8.91
9.47
10.78
Book Value[Incl.RevalReserv]/Share (Rs.)
8.50
8.53
8.91
9.47
10.78
Revenue From Operations / Share (Rs.)
0.37
0.24
0.63
0.75
2.49
PBDIT / Share (Rs.)
0.21
-0.02
-0.06
-0.39
0.25
PBIT / Share (Rs.)
-0.01
-0.36
-0.53
-0.82
-0.17
PBT / Share (Rs.)
-0.04
-0.39
-0.57
-1.29
-0.95
Net Profit / Share (Rs.)
-0.03
-0.38
-0.57
-1.31
-0.98
NP After MI And SOA / Share (Rs.)
-0.03
-0.38
-0.57
-1.31
-0.98
PBDIT Margin (%)
56.85
-9.66
-10.55
-52.32
10.07
PBIT Margin (%)
-2.35
-146.84
-85.02
-108.98
-7.09
PBT Margin (%)
-12.23
-156.99
-89.80
-170.48
-38.47
Net Profit Margin (%)
-8.16
-152.48
-90.22
-173.28
-39.61
NP After MI And SOA Margin (%)
-8.16
-152.48
-90.22
-173.28
-39.61
Return on Networth / Equity (%)
-0.36
-4.48
-6.46
-13.88
-9.18
Return on Capital Employeed (%)
-0.06
-2.56
-3.67
-5.36
-1.08
Return On Assets (%)
-0.21
-2.65
-3.87
-8.49
-6.03
Long Term Debt / Equity (X)
0.63
0.62
0.60
0.57
0.47
Total Debt / Equity (X)
0.63
0.62
0.60
0.57
0.47
Asset Turnover Ratio (%)
0.02
0.01
0.04
0.04
0.14
Current Ratio (X)
29.59
15.97
17.40
17.36
17.80
Quick Ratio (X)
29.46
15.89
17.10
17.01
17.49
Interest Coverage Ratio (X)
5.76
-0.95
-2.21
-0.85
0.32
Interest Coverage Ratio (Post Tax) (X)
0.17
-14.03
-17.86
-1.82
-0.26
Enterprise Value (Cr.)
10.00
10.11
9.76
9.95
10.69
EV / Net Operating Revenue (X)
17.63
26.84
10.18
8.72
2.84
EV / EBITDA (X)
31.01
-277.52
-96.45
-16.66
28.21
MarketCap / Net Operating Revenue (X)
3.12
5.29
1.67
1.46
0.78
Price / BV (X)
0.13
0.15
0.11
0.11
0.18
Price / Net Operating Revenue (X)
3.12
5.30
1.67
1.46
0.78
EarningsYield
-0.02
-0.28
-0.53
-1.19
-0.50
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Dolphin Medical Services Ltd as of February 5, 2025 is: ₹0.82
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of February 5, 2025, Dolphin Medical Services Ltd is Overvalued by 68.94% compared to the current share price ₹2.64
Default values used*: Default value of 15 for Stock P/E is used
Intrinsic Value of Dolphin Medical Services Ltd as of February 5, 2025 is: ₹0.84
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of February 5, 2025, Dolphin Medical Services Ltd is Overvalued by 68.18% compared to the current share price ₹2.64
Default values used*: Default value of 15 for Stock P/E is used
Last 5 Year EPS CAGR: 2.66%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Dolphin Medical Services Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: -0.36% (Industry Average ROE: 12.42%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 0 (Industry average Stock P/E: 56.27)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.63
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Dolphin Medical Services Ltd. is a Public Limited Listed company incorporated on 21/09/1992 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24239TG1992PLC014775 and registration number is 014775. Currently company belongs to the Industry of Hospitals & Medical Services. Company's Total Operating Revenue is Rs. 0.68 Cr. and Equity Capital is Rs. 15.10 Cr. for the Year ended 31/03/2024.
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Dolphin Medical Services Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
